Grant
$5.4m
Vaxxas awarded $5.4 million for typhoid vaccine clinical studies
Brisbane vaccine patch maker Vaxxas won a $5.4 million Wellcome grant for studies and a Phase I trial of a typhoid vaccine using its HD-MAP technology, developed with SK bioscience.